BACKGROUND: Antifibrotics are recommended for the treatment of individuals with idiopathic pulmonary fibrosis (IPF), but treatment use remains at approximately 60%. OBJECTIVE: To investigate the views of individuals with IPF and pulmonologists on the diagnosis and management of IPF to understand treatment patterns. METHODS: Interviews and/or online surveys were completed by patients and pulmonologists from Canada, France, Germany, Italy, Spain, and the UK. Responses from physicians were analyzed by time between diagnosis and treatment initiation in the majority of patients with IPF (group A, > 4 months; group B,
Maher, T. M.
Swigris, J. J.
Kreuter, M.
Wijsenbeek, M.
Cassidy, N.
Ireland, L.
Axmann, J.
Nathan, S. D.
Keywords
- Antifibrotic treatment
- Barriers to treatment
- Idiopathic pulmonary fibrosis
- Patient-physician communication
